SEC Form 4 · accession 0001005284-18-000048

UNIVERSAL DISPLAY CORP \PA\ · OLED

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chairman of Board and Founder · Director

Period of report

Mar 6, 2018

Accepted (ET)

Mar 8, 2018 · 7:29 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001005284

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1	Mar 6, 2018	A	1,440	$0.00	A	92,723	D
Common Stock^F2	Mar 6, 2018	A	4,120	$0.00	A	96,843	D
Common Stock^F3	Mar 6, 2018	F	1,129	$122.15	D	95,714	D
Common Stock^F4	Mar 7, 2018	F	180	$124.60	D	95,534	D
Common Stock^F5	holding	—	—		—	21,000	I	By Trust
Common Stock^F6	holding	—	—		—	136,000	I	By Corp.

No Table II lines on this filing.

F1These units were granted to Mr. Seligsohn under the Company's Long Term Incentive Plan as part of his 2018 compensation and are subject to a time-based vesting restriction, with one-third of the total unit amount vesting on each of March 6, 2019, 2020, and 2021.
F2These shares were granted to Mr. Seligsohn as performance units under the Company's Long Term Incentive Plan as part of his 2015 compensation and vested subject to the satisfaction of certain performance conditions, which our Compensation Committee certified on March 6, 2018 as having occurred.
F3These shares were withheld to satisfy a tax liability in connection with the vesting on March 6, 2018 of 4,120 shares of restricted stock previously granted to Mr. Seligsohn.
F4These shares were withheld to satisfy a tax liability in connection with the vesting on March 7, 2018 of 659 shares of restricted stock previously granted to Mr. Seligsohn.
F5The Seligsohn Foundation, of which Mr. Seligsohn is the sole trustee.
F6American Biomimetics Corporation, of which Mr. Seligsohn is the sole Director, Chairman, President and Secretary.